NewGenIvf Group Limited (NASDAQ:NIVF) Sees Significant Drop in Short Interest

NewGenIvf Group Limited (NASDAQ:NIVF) was the recipient of a significant drop in short interest during the month of June. As of June 15th, there was short interest totaling 89,521 shares, a drop of 54.0% from the May 31st total of 194,483 shares. Based on an average trading volume of 2,421,281 shares, the days-to-cover ratio is currently 0.0 days. Approximately 1.3% of the company’s shares are short sold.

Insider Buying and Selling

In other NewGenIvf Group news, major shareholder Financial Lp Hrt sold 85,317 shares of NewGenIvf Group stock in a transaction on Wednesday, May 27th. The shares were sold at an average price of $0.80, for a total transaction of $68,253.60. Following the completion of the sale, the insider owned 54,561 shares of the company’s stock, valued at approximately $43,648.80. The trade was a 60.99% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Corporate insiders own 31.80% of the company’s stock.

Wall Street Analyst Weigh In

Separately, Weiss Ratings restated a “sell (d)” rating on shares of NewGenIvf Group in a research report on Monday, April 27th. One investment analyst has rated the stock with a Sell rating, According to data from MarketBeat, the company presently has an average rating of “Sell”.

NewGenIvf Group Price Performance

Shares of NIVF stock traded up $0.02 on Wednesday, reaching $0.55. The company had a trading volume of 821,337 shares, compared to its average volume of 3,020,306. The company has a 50-day moving average of $1.04 and a 200-day moving average of $3.54. The company has a debt-to-equity ratio of 0.16, a quick ratio of 2.98 and a current ratio of 3.12. NewGenIvf Group has a 12 month low of $0.47 and a 12 month high of $318.00.

NewGenIvf Group (NASDAQ:NIVF) last released its quarterly earnings data on Tuesday, March 31st. The company reported ($287.24) earnings per share for the quarter. The company had revenue of $1.42 million for the quarter. As a group, equities research analysts expect that NewGenIvf Group will post 4.74 earnings per share for the current fiscal year.

About NewGenIvf Group

NewGenIVF Group Inc, trading on NASDAQ under the symbol NIVF, is an integrated provider of reproductive medicine services in the People’s Republic of China. The company operates a network of fertility clinics across major Chinese cities, delivering comprehensive infertility diagnosis and treatment to patients and couples. Its facilities are equipped with modern laboratories and surgical suites designed for assisted reproductive procedures.

NewGenIVF’s service offerings encompass a wide range of assisted reproductive technologies (ART), including in vitro fertilization (IVF), intracytoplasmic sperm injection (ICSI), preimplantation genetic testing (PGT), and fertility preservation through ovarian tissue and gamete cryopreservation.